nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever
|
Kamani, Christel H. |
|
|
47 |
8 |
p. 2036-2037 |
artikel |
2 |
A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB
|
Cho, Soo Hyun |
|
|
47 |
8 |
p. 1938-1948 |
artikel |
3 |
Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients
|
Schaeverbeke, Jolien |
|
|
47 |
8 |
p. 1949-1960 |
artikel |
4 |
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
|
Chen, Haojun |
|
|
47 |
8 |
p. 1820-1832 |
artikel |
5 |
Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis
|
Nihashi, Takashi |
|
|
47 |
8 |
p. 1984-1997 |
artikel |
6 |
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
|
Morbelli, Silvia |
|
|
47 |
8 |
p. 1885-1912 |
artikel |
7 |
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake
|
Hartrampf, Philipp E. |
|
|
47 |
8 |
p. 2044-2046 |
artikel |
8 |
F-18 FDG PET brain imaging in symptomatic arthroprosthetic cobaltism
|
Bridges, Robert L. |
|
|
47 |
8 |
p. 1961-1970 |
artikel |
9 |
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity
|
Zanoni, Lucia |
|
|
47 |
8 |
p. 2038-2039 |
artikel |
10 |
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab
|
van Oostenbrugge, Tim J. |
|
|
47 |
8 |
p. 1864-1870 |
artikel |
11 |
68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
|
Donato, Peter |
|
|
47 |
8 |
p. 1843-1851 |
artikel |
12 |
Hide-and-seek for radiotracers and neurodegenerative pathology
|
Herholz, Karl |
|
|
47 |
8 |
p. 1791-1792 |
artikel |
13 |
Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine—a global competition for excellence
|
Schwarzenböck, Sarah M. |
|
|
47 |
8 |
p. 1808-1819 |
artikel |
14 |
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
|
Schmidt-Hegemann, N.-S. |
|
|
47 |
8 |
p. 1852-1863 |
artikel |
15 |
Influence of the scan time point when assessing hypoxia in 18F-fluoromisonidazole PET: 2 vs. 4 h
|
Kobayashi, Kentaro |
|
|
47 |
8 |
p. 1833-1842 |
artikel |
16 |
In vivo characterization of [18F]AVT-011 as a radiotracer for PET imaging of multidrug resistance
|
Kannan, Pavitra |
|
|
47 |
8 |
p. 2026-2035 |
artikel |
17 |
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units
|
Assadi, Majid |
|
|
47 |
8 |
p. 1779-1786 |
artikel |
18 |
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
|
Ferrone, Cristina |
|
|
47 |
8 |
p. 1871-1884 |
artikel |
19 |
Molecular imaging of carotid artery atherosclerosis with PET: a systematic review
|
Piri, Reza |
|
|
47 |
8 |
p. 2016-2025 |
artikel |
20 |
Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain
|
Kramer, Vasko |
|
|
47 |
8 |
p. 1927-1937 |
artikel |
21 |
Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease
|
Khreish, Fadi |
|
|
47 |
8 |
p. 2040-2041 |
artikel |
22 |
Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant
|
Barthel, Henryk |
|
|
47 |
8 |
p. 1787-1790 |
artikel |
23 |
Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson’s disease
|
Delva, Aline |
|
|
47 |
8 |
p. 1913-1926 |
artikel |
24 |
Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis
|
Khor, Yiu Ming |
|
|
47 |
8 |
p. 1998-2009 |
artikel |
25 |
Reactions to COVID-19: actions of nuclear medicine healthcare personnel in China
|
Liu, Yan-Qing |
|
|
47 |
8 |
p. 1798-1801 |
artikel |
26 |
Reply to: Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise: emphasis should also be placed on the critical role of image analysis schemes
|
Alavi, Abass |
|
|
47 |
8 |
p. 1806-1807 |
artikel |
27 |
Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function
|
Fiechter, Michael |
|
|
47 |
8 |
p. 2010-2015 |
artikel |
28 |
Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
|
Kim, Jun Pyo |
|
|
47 |
8 |
p. 1971-1983 |
artikel |
29 |
Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?
|
Basu, Sandip |
|
|
47 |
8 |
p. 1793-1797 |
artikel |
30 |
Visualization of malignant infiltration of the thoracic duct on 68Ga PSMA-11 PET/CT in a prostate cancer patient with biochemical recurrence
|
Uprimny, Christian |
|
|
47 |
8 |
p. 2042-2043 |
artikel |
31 |
When nuclear medicine radiological protection meets biological COVID-19 protection
|
Vigne, Jonathan |
|
|
47 |
8 |
p. 1802-1805 |
artikel |